Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy

Clinical Research in Cardiology

Volumn 100, Issue 8, 2011, Pages 633-640

  Frankenstein, Lutz ^a   Remppis, Andrew ^a   Giannitis, Evangelos ^a   Frankenstein, Joerdis ^b   Hess, Georg ^c   Zdunek, Dietmar ^c   Doesch, Andreas ^a   Zugck, Christian ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Biovariability; High sensitive Troponin; High sensitivity assay; Reference change value

Indexed keywords

TROPONIN T;

ADULT; ARTICLE; CARDIAC PATIENT; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; SYSTOLIC DYSFUNCTION;

AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; TROPONIN T;

EID: 80051786336     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0285-4     Document Type: Article

References (29)

1. K Thygesen JS Alpert HD White The Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction 2007 Universal definition of myocardial infarction Eur Heart J 28 2525 2538 17951287 10.1093/eurheartj/ehm355 (Pubitemid 47616190)
2. Kurz K, Giannitsis E, Becker M, Hess G, Zdunek D, Katus HA (2010) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol [Epub ahead of print]
3. MP Hudson CM O'Connor WA Gattis G Tasissa V Hasselblad CM Holleman LH Gaulden F Sedor EM Ohman 2004 Implications of elevated cardiac troponin T in ambulatory patients with heart failure: A prospective analysis Am Heart J 147 546 552 14999208 10.1016/j.ahj.2003.10.014 1:CAS:528:DC%2BD2cXhslensLk%3D (Pubitemid 38880881)
4. ER Perna SM Macin JP Canella N Augier JL Stival JR Cialzeta AE Pitzus EH Garcia R Obregón M Brizuela A Barbagelata 2004 Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification Circulation 110 2376 2382 15477403 10.1161/01.CIR.0000145158.33801.F3 (Pubitemid 39407342)
5. R Alcalai D Planer A Culhaoglu A Osman A Pollak C Lotan 2007 Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis Arch Intern Med 167 276 281 17296884 10.1001/archinte.167.3. 276
6. Y Sato T Yamada R Taniguchi K Nagai T Makiyama H Okada K Kataoka H Ito A Matsumori S Sasayama Y Takatsu 2001 Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes Circulation 103 369 374 11157687 1:CAS:528:DC%2BD3MXhtF2ksLo%3D (Pubitemid 32105975)
7. JS Healey RF Davies SJ Smith RA Davies DS Ooi 2003 Prognostic use of cardiac troponin T and troponin I in patients with heart failure Can J Cardiol 19 383 386 12704483 1:CAS:528:DC%2BD3sXkvVCis7Y%3D (Pubitemid 36603504)
8. R Latini S Masson IS Anand E Missov M Carlson T Vago L Angelici S Barlera G Parrinello AP Maggioni G Tognoni JN Cohn Val-HeFT Investigators 2007 Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 1242 1249 17698733 10.1161/CIRCULATIONAHA.106.655076 1:CAS:528:DC%2BD2sXpvFWksbY%3D (Pubitemid 47517535)
9. AH Wu N Fukushima R Puskas J Todd P Goix 2006 Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector Clin Chem 52 2157 2159 18061987 10.1373/clinchem.2006.073163 1:CAS:528:DC%2BD28XhtFOktbzN
10. K Kurz E Giannitsis J Zehelein HA Katus 2008 Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia Clin Chem 54 1234 1238 18593962 10.1373/clinchem.2007.097865 1:CAS:528:DC%2BD1cXot1amsbs%3D (Pubitemid 352009701)
11. M Neizel H Steen G Korosoglou D Lossnitzer S Lehrke BT Ivandic HA Katus E Giannitsis 2009 Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study Clin Res Cardiol 98 297 304 19280086 10.1007/s00392-009-0002-8 1:CAS:528:DC%2BD1MXlt1Kjur0%3D
12. AHB Wu QA Lu J Todd J Moecks F Wians 2008 Short- and long-term biological variation for cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice Clin Chem 55 52 58 18988755 10.1373/clinchem.2008.107391
13. FS Apple LA Pearce SW Smith JM Kaczmarek MM Murakami 2009 Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events Clin Chem 55 930 937 19299542 10.1373/clinchem.2008.114728 1:CAS:528: DC%2BD1MXlsVWmtrk%3D
14. PA Kavsak DT Ko X Wan AR Macrae AS Jaffe 2010 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay Clin Chem 56 487 489 20075178 10.1373/clinchem.2009.136689 1:CAS:528:DC%2BC3cXivFCju7k%3D
15. AH Wu AS Jaffe 2008 The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing Am Heart J 155 208 214 18215588 10.1016/j.ahj.2007.10.016 1:CAS:528: DC%2BD1cXosV2iug%3D%3D
16. WL Miller KA Hartman MF Burritt JC Burnett Jr AS Jaffe 2007 Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies Clin Cardiol 30 245 250 17492679 10.1002/clc.20075 (Pubitemid 46802326)
17. L Frankenstein A Remppis J Frankenstein G Hess D Zdunek K Slottje HA Katus C Zugck 2009 Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables Clin Chem 55 923 929 19299545 10.1373/clinchem.2008.112052 1:CAS:528: DC%2BD1MXlsVWmtrg%3D
18. L Frankenstein A Remppis J Frankenstein G Hess D Zdunek S Gut K Slottje HA Katus C Zugck 2009 Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure Basic Res Cardiol 104 731 738 19352585 10.1007/s00395-009-0027-1
19. K Swedberg J Cleland H Dargie H Drexler F Follath M Komajda L Tavazzi OA Smiseth A Gavazzi A Haverich A Hoes T Jaarsma J Korewicki S Levy C Linde JL Lopez-Sendon MS Nieminen L Pierard WJ Remme Task Froce The Diagnosis, Treatment of Chronic Heart Failure of the European Society of Cardiology 2005 Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 1115 1140 15901669 10.1093/eurheartj/ehi166 (Pubitemid 41435461)
20. A Missbichler G Hawa N Schmal W Woloszczuk 2001 Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction Eur J Med Res 6 105 111 11309223 1:CAS:528:DC%2BD3MXivVOqs7g%3D
21. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine A new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D (Pubitemid 29135798)
22. PH Petersen S Sandberg CG Fraser H Goldschmidt 2001 Influence of index of individuality on false positives in repeated sampling from healthy individuals Clin Chem Lab Med 39 160 165 11341751 10.1515/CCLM.2001.027 1:CAS:528: DC%2BD3MXjsVynsbw%3D (Pubitemid 32318481)
23. N Iglesias PH Petersen C Ricós 2005 Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality Clin Chem Lab Med 43 441 448 15899662 10.1515/CCLM.2005.078 1:CAS:528:DC%2BD2MXktVCmt7c%3D (Pubitemid 41460652)
24. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 307 310 2868172 10.1016/S0140-6736(86)90837-8 1:STN:280:DyaL287hslWqsQ%3D%3D (Pubitemid 16134762)
25. JM Bland DG Altman 1999 Measuring agreement in method comparison studies Stat Methods Med Res 8 135 160 10501650 10.1191/096228099673819272 1:STN:280:DyaK1MvivFOmug%3D%3D (Pubitemid 29425900)
26. MR Fokkema Z Herrmann FA Muskiet J Moecks 2006 Reference change values for brain natriuretic peptides revisited Clin Chem 52 1602 1603 16873298 10.1373/clinchem.2006.069369 1:CAS:528:DC%2BD28XnvFahtLg%3D (Pubitemid 44148325)
27. MC Fishbein T Wang M Matijasevic L Hong FS Apple 2003 Myocardial tissue troponins T and I: an immunohistochemical study in experimental models of myocardial ischemia Cardiovasc Patho 12 65 71 10.1016/S1054-8807(02)00188-6 1:CAS:528:DC%2BD3sXislent7o%3D (Pubitemid 36401579)
28. Y Sato T Miyamoto R Taniguchi K Nagao T Matsuoka R Fukuhara Y Kuwabara K Isoda K Yamane K Nishi S Saijyo H Fujiwara Y Takatsu 2009 The clinical and haemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST J Cardiol 53 20 27 19167634 10.1016/j.jjcc.2008.08.004
29. A Jeremias CM Gibson 2005 Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded Ann Intern Med 142 786 791 15867411 (Pubitemid 40593781)